Mechanisms of action of the small conductance Ca2+-activated K+-channel modulator AP30663, a novel compound being developed for treatment of atrial fibrillation in man

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Preclinical pharmacotherapy Antiarrhythmic Pharmacotherapy ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by